![](https://investorshub.advfn.com/uicon/29747.png?cb=1464811254)
Saturday, May 18, 2024 9:01:45 AM
Recent ACET News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 11:01:37 AM
- Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma • Business Wire • 07/08/2024 11:00:00 AM
- Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/28/2024 09:00:00 PM
- Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma • Business Wire • 06/24/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:11:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:10:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:06:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:04:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:03:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:02:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 11:01:53 AM
- Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis • Business Wire • 06/05/2024 11:00:00 AM
- Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/31/2024 09:41:00 PM
- Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference • Business Wire • 05/29/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:05:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:03:01 PM
- Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates • Business Wire • 05/14/2024 08:01:00 PM
- Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress • Business Wire • 05/14/2024 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 10:09:04 AM
- Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference • Business Wire • 05/07/2024 11:00:00 AM
- Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/30/2024 09:10:00 PM
- Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting • Business Wire • 04/22/2024 08:30:00 PM
- Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference • Business Wire • 04/08/2024 11:00:00 AM
- Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/28/2024 09:19:00 PM
- Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress • Business Wire • 03/19/2024 08:10:00 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM